Oramed Pharmaceuticals

ORMP

Capitalización de mercado USD 172 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Renaissance Technologies New York	USD 395 k	-USD 121 k	-16,700	-24%
2	2 Barclays London, United Kingdom	USD 306 k	–	–	–
3	3 Morgan Stanley New York	USD 219 k	-USD 32.3 k	-4,448	-13%
4	4 BlackRock New York	USD 209 k	+USD 203 k	+28,041	Nuevas
5	5 PNC Financial Services Group Pittsburgh, Pennsylvania	USD 158 k	–	–	–
6	6 Glenmede Trust Philadelphia, Pennsylvania	USD 149 k	–	–	–
7	7 Deutsche Bank Frankfurt Am Main Ge, Germany	USD 131 k	-USD 53.1 k	-7,314	-29%
8	8 Rossmore Private Capital Glastonbury, Connecticut	USD 112 k	–	–	–
9	9 Wells Fargo San Francisco, California	USD 80 k	+USD 18.9 k	+2,600	+32%
10	10 UBS Group Zurich, Switzerland	USD 61 k	-USD 4.72 k	-650	-7%
11	11 Citigroup New York	USD 55 k	+USD 6.2 k	+855	+13%
12	12 Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania	USD 23 k	–	–	–
13	13 Bank of Montreal Toronto, Ontario, Canada	USD 19 k	–	–	–
14	14 Royal Bank of Canada Toronto, Ontario, Canada	USD 11 k	–	–	–
15	15 Bank of America Charlotte, North Carolina	USD 8 k	–	–	–
16	16 Advisor Group Phoenix, Arizona	USD 7 k	+USD 7.26 k	+1,000	Nuevas
17	17 Close Asset Management London, United Kingdom	USD 5 k	–	–	–
18	18 JFS Wealth Advisors Hermitage, Pennsylvania	USD 4 k	–	–	–
19	19 Ladenburg Thalmann Financial Services Miami, Florida	USD 3 k	–	–	–
20	20 Steward Partners Investment Advisory New York	USD 2 k	–	–	–
21	21 Landaas & Company Milwaukee, Wisconsin	USD 2 k	+USD 1.67 k	+230	Nuevas
22	22 ETF Managers Group Summit, New Jersey	–	-USD 86 k	-13,478	Cerradas
23	23 Financial Architects (New Jersey) Marlton, New Jersey	–	-USD 18 k	-2,750	Cerradas
24	24 Tower Research Capital (TRC) New York	–	-USD 2 k	-281	Cerradas

Oramed Pharmaceuticals ORMP Capitalización de mercado USD 172 M

Oramed Pharmaceuticals

ORMP

Capitalización de mercado USD 172 M